A report by Business Action for Africa titled Business and HIV/AIDS: What have we learnt? ( 1.2 MB) highlights the role that the private sector plays in tackling the impacts of HIV and AIDS in developing countries. It makes the…
Drugmaker Merck & Co. plans to donate enough doses of its cervical cancer vaccine, Gardasil, to inoculate 1 million women in some of the world's poorest countries. Whitehouse Station, N.J.-based Merck announced the gift today at the third annual Clinton…
Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical…
A decade ago the Minnesota Board of Medical Practice accused Dr. Faruk Abuzzahab of a “reckless, if not willful, disregard” for the welfare of 46 patients, 5 of whom died in his care or shortly afterward. The board suspended his…
GlaxoSmithKline is at the top of ethical-monitoring firm Covalence's ranking list, followed by Bristol-Myers Squibb and Johnson & Johnson. The quarterly report, which ranks the top 10 highest-ranking pharmas, reveals that the amount of revenue a company earns does not…
In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and…
The latest ethical reputations of the world's largest pharmaceutical companies have been revealed, with GlaxoSmithKline (GSK) emerging as big pharma's Mother Theresa, according to a recently-released compilation by Geneva-based ethical-monitoring firm Covalence. Interestingly, earning power and ethical nature do not…
Thailand may revoke the compulsory license issued for a generic version of Merck’s Efavirenz AIDS drugs after upbeat talks with the drugmaker. Thailand’s Public Health Minister Mongkol na Songkhla says Merck reps proposed several options that could lead to a…
Less than six months after the Thai public health ministry said it would issue a compulsory licence over a patent held by Merck for the AIDS treatment drug efavirenz, the Brazilian government has followed suit. The Brazilian president, Luiz Inà¡cio…
